DILON Diagnostics and GE Healthcare announce the FDA clearance of the Discovery NM 750b biopsy accessory

NEWPORT NEWS, Va., Nov. 25, 2016 /PRNewswire/ -- DILON Diagnostics and GE Healthcare are pleased to announce the FDA clearance of the Molecular Breast Imaging (MBI) localization accessory for breast biopsy. The Discovery NM750b and the breast biopsy accessory will be presented at the RSNA conference in Chicago, from November 27 to December 1. The Discovery NM750b will be at the Dilon booth number 6132. This important milestone in the breast imaging segment comes shortly after Dilon and GE signed an exclusive agreement for DILON to distribute GE's Discovery NM750b Molecular Breast Imaging system in North America.    

The Discovery NM 750b breast imaging system, designed to measure and image the distribution of selected single photon emission radioisotopes in the human body to aid in the evaluation of lesions, offers clinicians an important tool for imaging of a broad range of patients, including those with dense breast. The MBI localization accessory is a complementary technology to the Discovery NM750b breast imaging system which is designed to accurately locate, in three dimensions, lesions in the breast using information derived from stereotactic pairs of two-dimensional images. It is intended to provide guidance for interventional purposes such as biopsy and pre-surgical.

The power of functional imaging to see and localize early changes is a key factor in early detection of breast cancer.

About DILON Diagnostics
DILON Diagnostics, a brand of DILON Technologies, Inc., located in Newport News, Virginia, designs, manufactures and commercializes innovative medical imaging solutions worldwide.  DILON's cornerstone product, the DILON Molecular Imaging System, is a high-resolution, compact camera for imaging small body parts, such as the breast, thyroid, parathyroid and bone. The DILON Molecular Imaging System has been optimized to perform Molecular Breast Imaging (MBI/BSGI) procedure that aids in the effective management of suspicious and difficult-to-interpret breast cases. For more information on DILON Diagnostics please visit www.dilon.com

About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information visit our website www.gehealthcare.com

Media Contact: Pjerin Luli
P: 757-269-4910
E: pluli@dilon.com

Logo - http://photos.prnewswire.com/prnh/20140106/PH40697LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dilon-diagnostics-and-ge-healthcare-announce-the-fda-clearance-of-the-discovery-nm-750b-biopsy-accessory-300368667.html

SOURCE DILON Diagnostics